The role of temozolomide in the treatment of aggressive pituitary tumors.

Abstract excerpt

Pituitary tumors are amongst the most common intracranial neoplasms and are generally benign. However, some pituitary tumors exhibit clinically aggressive behavior that is characterized by tumor recurrence and continued progression despite repeated treatments with conventional surgical, radiation and medical therapies. More recently, temozolomide, a second generation oral alkylating agent, has shown therapeutic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Adenoma
• Share to Antineoplastic Agents, Alkylating